T. Rowe Price Associates »

Soleno Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-12-31 $73M 1.6M 44.95
2024-09-30 $66M 1.3M 50.49
2024-06-30 $20M 478k 40.83
2024-03-31 $6.5M 153k 42.81

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Tesla Comm Stk (TSLA)
Broadcom Comm Stk (AVGO)
Unitedhealth Group Comm Stk (UNH)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vivo Capital
State Street Corporation
Invesco
Caption Management
Adage Capital Partners GP
Commodore Capital
Braidwell
Millennium Management
Polar Capital Holdings

View all funds holding Soleno Therapeutics